TXNIP and acute respiratory distress syndrome: These findings indicate that linarin's ability to suppress p65NF‐κB and TXNIP/NLRP3 inflammasome activation plays a key role in mitigating airway inflammation, likely contributing to the overall anti‐inflammatory effects of DO in the LPS‐induced ALI model.